Caprock Group LLC Purchases New Holdings in Ventas, Inc. $VTR

Caprock Group LLC acquired a new position in Ventas, Inc. (NYSE:VTR) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 13,194 shares of the real estate investment trust’s stock, valued at approximately $898,000.

Several other large investors have also modified their holdings of the business. Arbor Capital Management Inc. ADV lifted its stake in shares of Ventas by 0.6% during the 3rd quarter. Arbor Capital Management Inc. ADV now owns 21,716 shares of the real estate investment trust’s stock worth $1,520,000 after acquiring an additional 137 shares during the last quarter. Foundations Investment Advisors LLC lifted its position in shares of Ventas by 3.3% during the third quarter. Foundations Investment Advisors LLC now owns 4,447 shares of the real estate investment trust’s stock worth $311,000 after purchasing an additional 144 shares during the last quarter. Ameritas Investment Partners Inc. boosted its stake in shares of Ventas by 3.8% during the second quarter. Ameritas Investment Partners Inc. now owns 4,260 shares of the real estate investment trust’s stock valued at $269,000 after purchasing an additional 155 shares during the period. Legacy Wealth Asset Management LLC boosted its stake in shares of Ventas by 3.8% during the second quarter. Legacy Wealth Asset Management LLC now owns 4,335 shares of the real estate investment trust’s stock valued at $274,000 after purchasing an additional 158 shares during the period. Finally, Checchi Capital Advisers LLC grew its holdings in shares of Ventas by 3.9% in the third quarter. Checchi Capital Advisers LLC now owns 4,603 shares of the real estate investment trust’s stock worth $322,000 after purchasing an additional 174 shares during the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Stock Down 0.1%

Shares of NYSE VTR opened at $85.15 on Monday. Ventas, Inc. has a 12-month low of $60.15 and a 12-month high of $87.20. The stock’s fifty day simple moving average is $78.54 and its two-hundred day simple moving average is $73.91. The stock has a market capitalization of $40.44 billion, a PE ratio of 157.68, a price-to-earnings-growth ratio of 2.11 and a beta of 0.77. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The company had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter last year, the company earned $0.81 earnings per share. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, analysts expect that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, March 31st. This is an increase from Ventas’s previous quarterly dividend of $0.48. Ventas’s payout ratio is presently 355.56%.

Analyst Ratings Changes

Several research firms have issued reports on VTR. Cantor Fitzgerald reissued an “overweight” rating and issued a $93.00 price objective on shares of Ventas in a research report on Monday, February 9th. Jefferies Financial Group reaffirmed a “buy” rating and set a $93.00 target price on shares of Ventas in a research report on Monday, December 15th. Scotiabank boosted their price target on Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a report on Thursday, November 13th. Wells Fargo & Company increased their price objective on Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Finally, Argus set a $88.00 price objective on Ventas in a report on Tuesday, February 10th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $86.87.

Insider Activity

In other Ventas news, CFO Robert F. Probst sold 29,930 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the sale, the chief financial officer directly owned 138,434 shares in the company, valued at $10,694,026.50. This trade represents a 17.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Peter J. Bulgarelli sold 2,771 shares of the company’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $80.01, for a total value of $221,707.71. Following the transaction, the chief executive officer directly owned 108,717 shares in the company, valued at approximately $8,698,447.17. The trade was a 2.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 91,106 shares of company stock worth $7,331,603. Insiders own 1.00% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.